Veterinary researchers at Oregon State University have identified a unique group of proteins that indicate the presence of transitional cell carcinoma, most common bladder cancer.
This might result in a reliable early detection test.
Bladder cancer is one of the diseases that doesn't give much warning. About 20% of dogs with bladder cancer have metastases at the time of diagnosis. The long-term prognosis is generally poor regardless of therapy.
The new test should improve the chances of catching the disease early for better treatment outcome.
It might even become an over-the-counter urine testing product.
The group of proteins identified in this research already have a 90 percent accuracy. Some of these proteins aren't only biomarkers of the disease but are involved in the disease process.
Understanding their involvement might also lead to new therapies.
Research could lead to new cancer assay, aid both dogs and humans